CHARLES NAU — Lobbyist Profile | Poliscope

CHARLES NAU

Reported covered position: N/A

Filings

Clients

Firms

Years active

2004–2016

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
JOHNSON & JOHNSON SERVICES INC	47	2004–2016

Lobbying firms

Firm	Filings	Years
JOHNSON & JOHNSON SERVICES, INC.	47	2004–2016

Bills explicitly cited in this lobbyist’s assigned issues (100)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (47)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · fourth_quarter · Q4

Firm income: —Client expense: $1,460,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act - Issues related to BARDA and other Ebola related matters. - Issues related to biosimilar reform.

BUD

Budget/Appropriations

- HR 83, "Consolidate and Further Continuing Appropriations Act, 2015", provisions related to emergency supplemental funding to address the Ebola epidemic domestically and internationally. - Issues related to the funding of the Biomedical Advanced Research and Development Authority. - Issues related to FDA Funding. - Issues related to VA procurement. - S. 3067/ HR 5485 - Financial Services and General Appropriations Act of 2017 - Issues related to FTC funding.

Source: Senate LDA

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Show 96 more cited filings

H.R. 1192

National Clinical Care Commission Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4075

Cosmetic Modernization Amendments of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4075

Cosmetic Modernization Amendments of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5485

Financial Services and General Government Appropriations Act, 2017

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5485

Financial Services and General Government Appropriations Act, 2017

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1014

Personal Care Products Safety Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1014

Personal Care Products Safety Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1014

Personal Care Products Safety Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1014

Personal Care Products Safety Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 277

Strengthening Research in Adult Education Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 277

Strengthening Research in Adult Education Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 277

Strengthening Research in Adult Education Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2777

Contact Lens Consumer Health Protection Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2994

DXM Abuse Prevention Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2994

DXM Abuse Prevention Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2994

DXM Abuse Prevention Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 3067

Financial Services and General Government Appropriations Act, 2017

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 3067

Financial Services and General Government Appropriations Act, 2017

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 632

STRONG Patents Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 632

STRONG Patents Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 632

STRONG Patents Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 632

STRONG Patents Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 993

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 993

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 993

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 993

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2977

MEDTECH Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2977

MEDTECH Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2977

MEDTECH Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2977

MEDTECH Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1078

Food and Drug Administration Safety Over Sequestration Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1854

Comprehensive Justice and Mental Health Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2646

Helping Families in Mental Health Crisis Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3250

DXM Abuse Prevention Act of 2015

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6

21st Century Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 83

CAMPER Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 9

Innovation Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1622

FDA Device Accountability Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1767

Combination Product Regulatory Fairness Act of 2016

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 2777, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions. - HR 1192, "National Clinical Care Commission Act", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · third_quarter · Q3

Firm income: —Client expense: $890,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 277, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions.

CPT

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · second_quarter · Q2

Firm income: —Client expense: $2,040,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 277, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package

CPT

BUD

Budget/Appropriations

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · first_quarter · Q1

Firm income: —Client expense: $1,140,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 277, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Show 43 more original filings

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · fourth_quarter · 4A

Firm income: —Client expense: $1,210,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - S. 1622, "The FDA Devise Accountablility Act", regarding all provisions. - S. 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions.

CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · fourth_quarter · Q4

Firm income: —Client expense: $1,260,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - S. 1622, "The FDA Devise Accountablility Act", regarding all provisions. - S. 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · third_quarter · Q3

Firm income: —Client expense: $780,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - S. 1622, "The FDA Devise Accountablility Act", regarding all provisions. - S. 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · second_quarter · Q2

Firm income: —Client expense: $2,420,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act

BUD

Budget/Appropriations

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · first_quarter · Q1

Firm income: —Client expense: $1,820,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - Issues related to 21st Century Cures. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · fourth_quarter · Q4

Firm income: —Client expense: $1,400,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions. - "Targeting Rogue Opaque Letters Act of 2014", regarding all provisons (no bill number).

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs. - Issues related to combination products. - Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications. - Issues related to Government Health Care Exclusion/ Debarment (bill number pending) - S 2977, "MEDTECH Act", regarding provisions related to medical mobile applications. - S 2917, "Adding Ebola to the FDA Priority Review Voucher Program Act", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · third_quarter · Q3

Firm income: —Client expense: $1,350,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · second_quarter · Q2

Firm income: —Client expense: $1,060,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · first_quarter · Q1

Firm income: —Client expense: $2,110,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · fourth_quarter · Q4

Firm income: —Client expense: $860,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- Issues related to patent reform. - Issues related to legislative proposals on patent "trolls".

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - S. 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013", regarding all provisions. - Issues related to health care associated infections. - S. 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · third_quarter · Q3

Firm income: —Client expense: $1,280,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to appropriations/debt ceiling.

CPT

- Issues related to patent reform.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · first_quarter · 1A

Firm income: —Client expense: $2,070,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · second_quarter · Q2

Firm income: —Client expense: $1,360,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/fiscal cliff.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · first_quarter · Q1

Firm income: —Client expense: $1,430,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/fiscal cliff.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · fourth_quarter · Q4

Firm income: —Client expense: $880,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/ fiscal cliff

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Access to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - HR 5937, "Breast Cancer Patient Education Act of 2012", regarding all provisions. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions. - S 3187, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - S 2516, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - HR 6584, Verifying Authority and Legality In Drug Compounding Act of 2012, regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · third_quarter · Q3

Firm income: —Client expense: $1,420,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/ fiscal cliff

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Access to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - HR 5937, "Breast Cancer Patient Education Act of 2012", regarding all provisions. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions. - S 3187, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - S 2516, "Food and Drug Administration Safety and Innovation Act", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · second_quarter · Q2

Firm income: —Client expense: $1,200,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding.

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Acess to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · first_quarter · Q1

Firm income: —Client expense: $2,260,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding. - Issues related to the Joint Committe on Deficit Reduction. - Issues related to FDA funding. - Issues related to Alzheimer's funding.

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Acess to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · fourth_quarter · Q4

Firm income: —Client expense: $930,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

- HR 1249, "The America Invents Act", regarding all provisions.

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - Issues related to the Better Act - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Physician Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · third_quarter · Q3

Firm income: —Client expense: $1,770,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

- Issues related to ADAP funding.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · second_quarter · Q2

Firm income: —Client expense: $1,300,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

CPT

- HR 1249, "The America Invents Act", regarding all provisions.

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · first_quarter · Q1

Firm income: —Client expense: $1,710,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

CPT

- HR 1249, "The America Invents Act", regarding all provisions.

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2010 · fourth_quarter · Q4

Firm income: —Client expense: $850,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

MMM

Medicare/Medicaid

- CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions. - H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions. - H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP. - Implementation of Health Care Reform Bill: Medicare Wellness Benefit. - H.R. 6130, "Strengthening Medicare Anti-Fraud Measures Act of 2010", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2010 · third_quarter · Q3

Firm income: —Client expense: $2,410,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 3397, "An Act to Amend the Controlled Substances Act to provide for take-back Disposal of Controlled Substances in certain instances and for other purposes", regarding all provisions.

ENV

Environment/Superfund

- H.R. 2454, "To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy", regarding all provisions. - H.R. 1262, "To amend the Federal Water Pollution Control Act to authorize appropriations for state water pollution control revolving funds, and for other purposes", regarding all provisions. - S. 1005, "A bill to amend the Federal Water Pollution Control Act and the Safe Drinking Water Act to improve water and wastewater infrastructure in the United States", regarding all provisions. - H.R. 1145, "To implement a National Water Research and Development Initiative, and for other purposes", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2010 · second_quarter · Q2

Firm income: —Client expense: $1,150,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

CPT

- H.R. 1260 / S. 1, "To amend title 35, United States Code, to provide for patent reform", regarding all provisions.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2010 · first_quarter · Q1

Firm income: —Client expense: $2,110,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2009 · fourth_quarter · 4A

Firm income: —Client expense: $1,640,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - S. 1679, "To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - S.1796, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3590, "An Act entitled The Patient Protection and Affordable Care Act", regarding all provisions. - H.R. 3962, "To provide affordable, quality health care for all Americans and reduce the growth in helaht care spending, and for other purposes.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2009 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

MMM

Medicare/Medicaid

- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions. - H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions. - H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2009 · third_quarter · Q3

Firm income: —Client expense: $1,660,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

HCR

Health Issues

- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. - "Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. - House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - H.R. 3200, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions. - Chairman's Mark, "America's Healthy Future Act of 2009", (bill not yet introduced), regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2009 · second_quarter · Q2

Firm income: —Client expense: $1,555,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

HCR

Health Issues

- H.R. 1897 / S. 803, "A bill to amend the internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes", regarding all provisions. - H.R. 759, "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes", regarding all provisions. - H.R. 1427, "To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes", regarding all provisions. - H.R. 1548 / S. 726, "To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes", regarding all provisions. - H.R. 2 / S. 275, "To amend title XXI of the Social Security Act to extend and improve the Children's Health Insurance Program, and for other purposes", regarding all provisions. - H.R. 1296, "To achieve access to comprehensive primary health care services for all Americans and to reform the organization of primary care delivery through an expansion of the Community Health Center and National Health Service Corps programs", regarding all provisions. - Issues relating to the "Comparative Effectiveness Research Act of 2008", regarding all provisions. -"Affordable Health Choices Act- To make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce", regarding all provisions. -House Energy & Commerce Committee Discussion Draft, "To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2009 · first_quarter · Q1

Firm income: —Client expense: $1,530,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

CPT

- H.R. 1260 / S. 1, "To amend title 35, United States Code, to provide for patent reform", regarding all provisions.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · fourth_quarter · 4A

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

ENV

Environment/Superfund

-S. 2191, "America's Climate Security Act of 2007", regarding a provision to direct the Administrator of the Environmental Protection Agency to establish a program to decrease emissions of greenhouse gases, and for other purposes.

MMM

Medicare/Medicaid

-H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; -Proposed Rule (CMS-1404-P), "CY 2009 Outpatient Prospective Payment System Rules". -H.R. 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; -H.R. 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; -H.R. 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; -H.R. 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; -H.R. 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; -H.R. 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; -H.R. 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; -H.R. 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; -H.R. 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; -S. 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; -S. 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; -S. 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; -CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; -CMS-2238-FC, regarding the Medicaid program, and prescription drugs; -S. 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. -S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; -H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; -H.R. 6252, "Medicare DMEPOS Competitive Acquisition Reform Act of 2008", To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies, regarding all provisions; -S. 2404, "Medicare Advanced Laboratory Diagnostics Act of 2007", A bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule, regarding all provisions; -H.R. 6331/ S. 3101, "Medicare Improvements for Patients and Providers Act of 2008", A bill to amend titles XVIII and XI of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes, regarding all provisions; -H.R. 2770, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · fourth_quarter · 4A

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

CPT

-H.R. 1908 / S. 1145, "Patent Reform Act of 2007," regarding amending title 35, United States Code, to provide for patent reform; -Thailand Compulsory License.

BUD

Budget/Appropriations

-H.R. 3043 / S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations; -H.R. 3161 / S. 1859, "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008," regarding drug importation; -H. Con. Res. 99, "Revising the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 though 2012," regarding healthcare funding issues.

HCR

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · fourth_quarter · Q4

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

MMM

Medicare/Medicaid

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · third_quarter · Q3

Firm income: —Client expense: $1,500,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

BUD

Budget/Appropriations

HCR

Health Issues

-H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; -H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions;

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · second_quarter · Q2

Firm income: —Client expense: $1,700,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

MMM

Medicare/Medicaid

H.R. 1190, "Community Cancer Care Preservation Act of 2007," regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321,Medicare Advanced Laboratory Diagnostics Act of 2007, regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule; HR 1663, Medicare Mental Health Modernization Act of 2007, regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, Medicare Durable Medical Equipment Access Act of 2007, regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price, all provisions; HR 3011, To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program, regarding all provisions; HR 3061, Medicare Part D Drug Class Protection Act of 2007, regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, Medicare Prescription Drug Price Negotiation Act of 2007, regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, Children's Health Insurance Program Reauthorization Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007, regarding improving enrollment and retention of eligible children; S 1887, Medicare Access to Critical Medications Act of 2007, regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, Remote Monitoring Access Act of 2007, regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, Early Treatment for HIV Act of 2007, regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues, regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs; S 2499, "Medicare, Medicaid, and SCHIP Extension Act of 2007," all provisions. S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP; H.R. 5765 / S. 631, "Medicare Remote Monitoring Access Act of 2008," regarding amending title XVIII of the Social Security Act to cover remote patient management services for certain chronic health conditions under the Medicare Program; H.R. 6252, "To amend part B of title XVIII of the Social Security Act to delay and reform the Medicare competitive acquisition program for purchase of durable medical equipment, prosthetics, orthotics, and supplies", regarding all provisions; S. 2404, "A bill to amend title SVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule", regarding all provisions; H.R. 6331/ S. 3101, "A bill to amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2008 · first_quarter · Q1

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

MMM

Medicare/Medicaid

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2007 · year_end · YY

Firm income: —Client expense: $3,880,000Open original LDA filing ↗

Assigned issues and filing targets (11 issues)

CSP

Consumer Issues/Safety/Products

HR 3610, "Food and Drug Import Safety Act of 2007," regarding fees related to food safety.

BUD

Budget/Appropriations

HR 3043 / S 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, regarding appropriations; HR 3161 / S 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008, regarding drug importation;

TAX

Taxation/Internal Revenue Code

HR 1712, Research and Development Tax Credit Act of 2007, regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness;

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2007 · mid_year · MM

Firm income: —Client expense: $3,820,000Open original LDA filing ↗

Assigned issues and filing targets (10 issues)

HCR

Health Issues

HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine. HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2006 · year_end · YY

Firm income: —Client expense: $2,080,000Open original LDA filing ↗

Assigned issues and filing targets (8 issues)

MMM

Medicare/Medicaid

Competitive Bidding for DME Implementation of DRA In-Vitro Diagnostics Legislation Medicare Competitive Acquistion Program (CAP) Medicare Competitive Bidding for Durable Medical Equipment Medicare Fraud and Abuse Medicare Part B Drug Payment Reform Medicare Part D Implementation Medicare Payment Policy Medicare Hospital Outpatient Rule Medicare Pay for Performance - Inpatient Prospective Payment System - Proposed Rule Medicare Coverage of I-BOT Medicaid Reform Mental Health Limitation for Scientific Products Pain Management Legislation Physician Fee Schedule Rule Out Patient Physician System Self-Administration Rule HR 328, HR 376, S 334, S 813 - Medicare Prescription Drug Coverage and Pricing Information HR 4157 - HIT/ICD-10 Coding HR 5179 - Amend Title XVIII of Social Security Act HR 5369 - Advanced Laboratory Diagnostics Act of 2006 HR 5465, S 340 Community Cancer Care Preservation Act of 2006 HR 6063- Remote Monitoring Legislation S 239, S 445 - Medicare Prescription Druge Coverage and Pricing Non-Interference AIDS Drugs Assistance Program Appropriations Chronic Care Improvement Program (CCIP) Clinical Lab Fee Schedule Reimbursement Rates Competitive Bidding for Laboratory Services

CPT

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2005 · mid_year · MM

Firm income: —Client expense: $2,020,000Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2004 · year_end · YY

Firm income: —Client expense: $2,200,000Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2004 · mid_year · MA

Firm income: —Client expense: $2,300,000Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

HCR

Health Issues

-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.

MMM

Medicare/Medicaid

HCR

Health Issues

MMM

Medicare/Medicaid

HCR

Health Issues

H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; H.R. 5839, "To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs", regarding all provisions; S. 334, "A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away", regarding all provisions; H.R. 6381, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions; S. 438, "A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs", regarding all provisions.

HCR

Health Issues

MMM

Medicare/Medicaid

HR 1663, “Medicare Mental Health Modernization Act of 2007,” regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, “Medicare Durable Medical Equipment Access Act of 2007,” regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, “To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price,” all provisions; HR 3011, “To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program,” regarding all provisions; HR 3061, “Medicare Part D Drug Class Protection Act of 2007,” regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, “Medicare Prescription Drug Price Negotiation Act of 2007,” regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, “Children's Health Insurance Program Reauthorization Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide tax relief for small businesses; HR 3162, “Children's Health and Medicare Protection Act of 2007,” regarding improving enrollment and retention of eligible children; S 1887, “Medicare Access to Critical Medications Act of 2007,” regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, “Remote Monitoring Access Act of 2007,” regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, “Early Treatment for HIV Act of 2007,” regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, “Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues,” regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs. HR 1190, “Community Cancer Care Preservation Act of 2007,” regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321, “Medicare Advanced Laboratory Diagnostics Act of 2007,” regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule;